Mutual Fund Feb 2020 share holdings and fund action in Suven Pharmaceuticals Ltd.

Suven Pharmaceuticals Ltd.

NSE: SUVENPHAR | BSE: 543064

Expensive Performer

Download real time

1081.70 28.45 (2.70%)

80.89% Gain from 52W Low

217.9K NSE+BSE Volume

NSE 08 Apr, 2025 3:52 PM (IST)

-0.2

MF holding change 1Month %

-0.2

MF holding change 2Month %

0.7

MF holding change 3Month%

Analyst Buy

Goldman Sachs initiates a 'Buy' rating on Suven Pharma; sets a target price of Rs 1,350 See details

MF	Feb-2020	Jan-2020	Dec-2019
Aditya Birla Sun Life Pure Value Fund Growth	56.47	1.55%	2,151,827	2,151,827	100%	-	-%	-	-%
ICICI Prudential BSE 500 ETF	0.01	0.02%	467	467	100%	-	-%	-	-%
Total:			2,152,294	2,152,294		0		0

Feb-2020

Jan-2020

Dec-2019

AUM (Rs Cr)

AUM %

Shares Held

Month Change in Shares

Month Change in Shares %

Shares Held

Month Change in Shares %

Shares Held

Month Change in Shares %

Aditya Birla Sun Life Pure Value Fund Growth

56.47

1.55%

2,151,827

100%

ICICI Prudential BSE 500 ETF

0.01

0.02%

467

100%

Total:

2,152,294

80.89% Gain from 52W Low

Aditya Birla Sun Life Pure Value Fund Growth was the highest buyer of 2,151,827 shares in Feb 2020 constituting 0.85% of the paid up equity of the company.

Shareholding Stock Screeners

80.89% Gain from 52W Low

Mutual Fund Feb 2020 share holdings and fund action in Suven Pharmaceuticals Ltd.

2 MFs bought and 0 MFs sold Suven Pharmaceuticals Ltd. in the month of Feb 2020 for a net change of 2,152,294 stocks

Aditya Birla Sun Life Pure Value Fund Growth was the highest buyer of 2,151,827 shares in Feb 2020 constituting 0.85% of the paid up equity of the company.

Shareholding Stock Screeners